Ticagrelor Hydrochloride is a potent P2Y12 receptor antagonist and antiplatelet agent indicated for the prevention of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary… Read more
Ticagrelor Hydrochloride is a potent P2Y12 receptor antagonist and antiplatelet agent indicated for the prevention of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of heart attack. This category provides comprehensive reference standards for the drug, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous analytical testing, such as impurity profiling, method validation, and quality control workflows. By utilizing these standards, researchers can ensure accurate identification and quantification of impurities, as well as precise bioanalytical results in pharmacokinetic studies. The inclusion of stable isotope labelled standards allows for the effective correction of matrix effects during mass spectrometry, ensuring the reliability of data required for regulatory compliance and drug safety assessments.